The trajectory of Viagra, initially marketed by copyright, presents a fascinating case study for stakeholders considering the drug arena . While its groundbreaking success and creation of countless in earnings , the patent lapse has opened the door for alternative medications, substantially eroding profit potential . This transition raises doubts a